AlemtuzumabHypersensitivity managed with desensitisation: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1489卷 / 1期

关键词：

D O I：

10.1007/s40278-014-8898-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：6 / 6

相关论文

共 50 条

[1] FurosemideHypersensitivity managed by desensitisation: case report
Reactions Weekly, 2010, 1294 (1) : 20 - 20
[2] CeftriaxoneAnaphylaxis managed by desensitisation: case report
Reactions Weekly, 2009, 1265 (1) : 13 - 13
[3] OmalizumabHypersensitivity managed with desensitisation: case report
Reactions Weekly, 2014, 1489 (1) : 28 - 28
[4] NatalizumabHypersensitivity managed with desensitisation: case report
Reactions Weekly, 2010, 1286 (1) : 24 - 24
[5] InsulinsAllergy, managed with desensitisation: case report
Reactions Weekly, 2014, 1517 (1) : 113 - 113
[6] DoxycyclineAnaphylaxis, managed with desensitisation: case report
Reactions Weekly, 2013, 1467 (1) : 16 - 16
[7] CisplatinHypersensitivity reaction, managed with desensitisation: case report
Reactions Weekly, 2014, 1520 (1) : 67 - 67
[8] IodixanolAnaphylactoid reaction managed by desensitisation: case report
Reactions Weekly, 2015, 1547 (1) : 163 - 163
[9] EtoposideHypersensitivity in a child, managed with desensitisation: case report
Reactions Weekly, 2010, 1307 (1) : 24 - 24
[10] EfavirenzHypersensitivity reaction managed with desensitisation: case report
Reactions Weekly, 2012, 1410 (1) : 20 - 20

← 1 2 3 4 5 →